Ilan Daskal - 01 Sep 2021 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, Chief Financial Officer
Signature
/s/ Ilan Daskal
Issuer symbol
BIO
Transactions as of
01 Sep 2021
Net transactions value
-$386,131
Form type
4
Filing time
03 Sep 2021, 17:02:51 UTC
Previous filing
05 Aug 2021
Next filing
08 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $283,122 +540 +7714% $524.30 547 02 Sep 2021 Direct
transaction BIO Bio-Rad A Common Stock Sale $364,320 -440 -80% $828.00 107 02 Sep 2021 Direct
transaction BIO Bio-Rad A Common Stock Sale $82,801 -100 -93% $828.01 7 02 Sep 2021 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +541 +7729% $0.000000 548 02 Sep 2021 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $222,132 -269 -49% $825.77 279 02 Sep 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Award $0 +1,823 $0.000000 1,823 01 Sep 2021 Bio-Rad A Common Stock 1,823 $0.000000 Direct F2, F3
transaction BIO Non-Qualified Stock Option (right to buy) Award $0 +1,823 $0.000000 1,823 01 Sep 2021 Bio-Rad A Common Stock 1,823 $814.95 Direct F4
transaction BIO Non-Qualified Stock Option (right to buy) Options Exercise $0 -540 -25% $0.000000 1,626 02 Sep 2021 Bio-Rad A Common Stock 540 $524.30 Direct F5
transaction BIO Restricted Stock Units Options Exercise $0 -541 -25% $0.000000 1,625 02 Sep 2021 Bio-Rad A Common Stock 541 $0.000000 Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F4 The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.
F5 The option, representing a right to purchase a total of 2,166 shares, became exercisable in four equal annual installments beginning on September 2, 2021, which was the first anniversary of the date on which the option was granted.
F6 On September 2, 2020, the reporting person was granted 2,166 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.